InsurTech venture funding held steady in February, with approximately $376 million deployed across a dozen deals—but the composition of those deals tells a sharper story than the top-line number suggests.
AI-native platforms captured the clear majority of capital, and eight of twelve recorded transactions targeted backend infrastructure: underwriting automation, policy management, claims orchestration, and payments. Consumer-facing propositions were nearly absent. The market is placing its bets on operational plumbing, not front-end polish.
The figures, drawn from a Digital Insurance review of roughly 35 total funding events and supplemented by deal-level analysis from InsurTech Analyst, paint a picture consistent with the trajectory set in 2025. According to Gallagher Re, full-year 2025 InsurTech investment reached $5.08 billion—a 19.5% annual increase—with two-thirds of that capital flowing to AI-focused firms. February’s pattern confirms the trend is accelerating, not plateauing.
Where the capital went
Stockholm-based Lassie led the month’s venture activity with a $75 million Series C to scale its prevention-first pet insurance model across Europe. The company reports over $100 million in annual recurring revenue and claims that 60% of its German claims now process end-to-end in roughly six minutes—a benchmark that illustrates what automation-first underwriting looks like in practice.
Two AI-driven platforms each secured $50 million: mea, an insurance-specific AI company that has processed more than $400 billion in gross written premium across 21 countries, took its first external capital from growth investor SEP; and Indigo, a vertically integrated medical professional liability insurer, closed an oversubscribed Series B to expand its proprietary underwriting platform, Lux.
The standout early-stage story was Harper, an AI-powered commercial brokerage that raised $47 million in combined seed and Series A—the largest publicly disclosed Series A by a Black founder. Harper automates submission routing, quote management, and underwriter liaison, claiming 24-to-48-hour coverage delivery for complex commercial risks. The company has served over 5,000 businesses in 13 months.
Artificial Labs ($45 million Series B) and ManageMy ($45 million) rounded out the mid-tier deals, both targeting digital broking and policy lifecycle management for carriers and intermediaries. Avantos pulled in $35 million for AI-native client onboarding in financial services, while Equal Parts ($23 million) and Pasito ($21 million) addressed agency acquisition infrastructure and AI-driven benefits administration, respectively.
Smaller but notable: Advance raised $8.55 million to modernize premium payment infrastructure for MGAs and wholesalers; General Magic secured $7.2 million for AI agents that reduced time-to-quote from 30 minutes to under three minutes in an early carrier deployment; Comeryx raised $7.5 million for AI-native small commercial underwriting; and Qumis closed a $4.3 million seed round for attorney-trained coverage intelligence.
The so what: infrastructure is the investment thesis
The concentration of capital in backend infrastructure and operational AI is not accidental. It reflects a market conviction that the next layer of insurance value creation sits between the carrier’s core systems and the customer’s experience—in the orchestration, decisioning, and data layers that legacy platforms cannot deliver.
This aligns with a broader pattern. CB Insights recently noted that investors making four or more InsurTech investments in 2025 fell to their lowest level since 2017, and those who remained active concentrated bets on companies with top-percentile quality scores. Fewer investors, higher bars, and a strong preference for companies that solve operational pain points rather than invent new distribution channels.
The geographic concentration reinforces the thesis: eight of twelve February deals originated in the United States, with the UK and Sweden contributing one each and Australia accounting for the remainder. Capital at the monthly level remains heavily clustered around established InsurTech ecosystems even as larger quarterly deal tables show more geographic diversity.
What to watch
Three signals are worth tracking from here. First, whether February’s AI dominance translates into measurable ROI disclosures—Gallagher Re’s Andrew Johnston has flagged the industry’s looming “so what” problem: efficiency gains from AI must eventually convert into provable business outcomes, or the current capital enthusiasm will cool. Second, early-stage deal sizes remain compressed; average seed rounds have trended near multi-year lows, suggesting that pre-revenue InsurTechs face a harder fundraising environment than their later-stage peers. Third, the near-total absence of consumer-facing InsurTech funding in February deserves attention—the market’s bet on B2B infrastructure may leave a gap in consumer innovation that takes years to fill.
February’s deal flow confirms that InsurTech capital has entered a selectivity phase: fewer checks, larger conviction bets, and a market that rewards companies solving the hard operational problems inside insurance rather than wrapping them in a better interface.
